These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25260805)

  • 21. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
    Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
    Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
    Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
    J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of genetics, epigenetics and variations in the transcriptional expression of cadherin-E in breast cancer susceptibility].
    Aristizábal-Pachón AF; Takahashi CS
    Biomedica; 2016 Dec; 36(4):593-602. PubMed ID: 27992986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors.
    Lombaerts M; Middeldorp JW; van der Weide E; Philippo K; van Wezel T; Smit VT; Cornelisse CJ; Cleton-Jansen AM
    Biochem Biophys Res Commun; 2004 Jun; 319(2):697-704. PubMed ID: 15178462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma.
    D'Urso PI; D'Urso OF; Storelli C; Catapano G; Gianfreda CD; Montinaro A; Muscella A; Marsigliante S
    J Neurooncol; 2011 Aug; 104(1):113-8. PubMed ID: 21127944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of expression level and methylation profile of
    Mohammadi Z; Azad M; Foroughi F; Khojastehpour S; Gheibi N; Samiee-Rad F; Maali A; Ahmadi MH
    J Cancer Res Ther; 2021; 17(6):1328-1334. PubMed ID: 34916361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic inactivation of E-cadherin by promoter hypermethylation in oral carcinoma cells.
    Maeda G; Chiba T; Aoba T; Imai K
    Odontology; 2007 Jul; 95(1):24-9. PubMed ID: 17660978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
    Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
    Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.
    Azarschab P; Porschen R; Gregor M; Blin N; Holzmann K
    Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.
    Graziano F; Arduini F; Ruzzo A; Bearzi I; Humar B; More H; Silva R; Muretto P; Guilford P; Testa E; Mari D; Magnani M; Cascinu S
    Clin Cancer Res; 2004 Apr; 10(8):2784-9. PubMed ID: 15102685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation.
    González-Martínez S; Kajabova VH; Pérez-Mies B; Carretero-Barrio I; Caniego-Casas T; Sarrió D; Moreno-Bueno G; Gión M; Perez-García J; Cortés J; Smolkova B; Palacios J
    Virchows Arch; 2024 Aug; 485(2):291-297. PubMed ID: 38713384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
    Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDH1 gene promoter hypermethylation in gastric cancer: relationship to Goseki grading, microsatellite instability status, and EBV invasion.
    Zazula M; Ferreira AM; Czopek JP; Kolodziejczyk P; Sinczak-Kuta A; Klimkowska A; Wojcik P; Okon K; Bialas M; Kulig J; Stachura J
    Diagn Mol Pathol; 2006 Mar; 15(1):24-9. PubMed ID: 16531765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of gene promoter methylation and mRNA, protein expression levels of E-cadherin in nasopharyngeal carcinoma].
    Li Z; Lin SX; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):25-30. PubMed ID: 12760799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
    Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer.
    Wheeler JM; Kim HC; Efstathiou JA; Ilyas M; Mortensen NJ; Bodmer WF
    Gut; 2001 Mar; 48(3):367-71. PubMed ID: 11171827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of CDH1 gene promoter methylation on expression of E-cadherin and beta-catenin and its clinicopathological significance in colon carcinoma].
    Li C; Dong J; Chen MQ; Li WL; Ren JY; Chen SX; Li QT; Geng JW; Miao YD; Yang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jul; 14(7):538-41. PubMed ID: 21792768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.
    Berx G; Van Roy F
    Breast Cancer Res; 2001; 3(5):289-93. PubMed ID: 11597316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.